Is trace mitral (mitral valve) and tricuspid (tricuspid valve) regurgitation a normal finding in a 36-year-old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trace Mitral and Tricuspid Regurgitation in a 36-Year-Old Female

Trace mitral and tricuspid regurgitation is a normal finding in a 36-year-old female and does not require intervention or follow-up. 1

Normal Physiological Finding

  • Trace to mild tricuspid and mitral valve regurgitation is commonly detected by Doppler echocardiography in healthy individuals without structural heart disease 1
  • Normal pregnancy is accompanied by echocardiographic evidence of mild ventricular chamber enlargement, and most women demonstrate Doppler evidence of "physiological" mitral regurgitation in the absence of structural valve disease 1
  • Pulmonic and tricuspid valvular regurgitation, as assessed by Doppler interrogation, is the rule rather than the exception in normal individuals 1

Distinguishing Normal from Pathological Regurgitation

  • Clinically insignificant tricuspid regurgitation is detected by color Doppler imaging in many normal persons and is not an indication for either routine follow-up or prophylaxis against bacterial endocarditis 1
  • Trace regurgitation differs significantly from pathological regurgitation based on several echocardiographic parameters:
    • Mild/trace MR: Small, central jet with faint/parabolic CW signal 1
    • Mild/trace TR: Small, central jet with faint/parabolic CW signal and normal right heart chambers 1

When to Be Concerned

  • Regurgitation becomes clinically significant when:
    • Tricuspid regurgitation: Vena contracta width ≥7mm, large flow convergence, systolic flow reversal in hepatic veins, or right atrial/ventricular enlargement 1
    • Mitral regurgitation: Vena contracta width ≥7mm, large central jet or eccentric wall-impinging jet, dense/triangular CW signal, or left atrial/ventricular enlargement 1
  • Significant tricuspid regurgitation is associated with elevated pulmonary artery pressures (>55 mmHg), whereas TR occurring with systolic pulmonary artery pressures <40 mmHg is likely to reflect a structural abnormality of the valve apparatus 1

Risk Factors for Progressive Regurgitation

  • Female sex is a risk factor for development of more significant tricuspid regurgitation over time 2
  • Other risk factors for progression include:
    • Preexisting atrial fibrillation 3
    • Diabetes mellitus 3
    • Elevated right ventricular systolic pressure 2
    • Older age 2

Clinical Implications

  • In the absence of symptoms, structural valve abnormalities, chamber enlargement, or pulmonary hypertension, trace mitral and tricuspid regurgitation does not require:
    • Routine follow-up echocardiography 1
    • Endocarditis prophylaxis 1
    • Any specific treatment or intervention 1
  • The European Association of Cardiovascular Imaging confirms that trace regurgitation falls below the threshold for even "mild" regurgitation in formal grading systems 1

Conclusion

Trace mitral and tricuspid regurgitation in a 36-year-old female represents a normal physiological finding that does not require clinical intervention or follow-up. This is supported by multiple cardiology guidelines that recognize the presence of minimal regurgitation as a common finding in healthy individuals 1. Clinical judgment should accompany echocardiographic results, as the finding of trace regurgitation alone without other abnormalities is not clinically significant.

Related Questions

How to manage patients with tricuspid and mitral regurgitation but normal valve appearance on echocardiogram?
What is the management plan for a patient with mild aortic, mitral, and tricuspid valve regurgitation, and mild aortic valve sclerosis, with normal left and right ventricular size and function?
What is the best course of treatment for a patient with tricuspid regurgitation and mitral regurgitation, but normal echocardiogram results, including normal valve function and ejection fraction?
What is the diagnosis for a patient with normal aortic, mitral, and tricuspid valve structures, trivial mitral and tricuspid regurgitation, and no stenosis, with peak velocities of 1.7 m/s in the aortic valve, 1.2 m/s in the mitral valve, and 1.2 m/s in the tricuspid valve?
What are the management and treatment options for a patient with mild aortic regurgitation (AR), mild tricuspid regurgitation (TR), trivial pulmonary regurgitation (PR), and suspected supravalvular stenosis in the main pulmonary artery (PA) with a left ventricular ejection fraction (LVEF) of 60-65%?
What test is used to check for hepatitis A immunity after Twinrix (hepatitis A and hepatitis B vaccine) vaccination?
What is the best approach to manage left hip pain in a 66-year-old male with a history of Hepatitis C, recent fall, and past trauma to the hip?
What diagnostic tests should be ordered for an 85-year-old female with chest pain?
What is the first step in treating hyperkalemia?
What is the recommended antibiotic for treating a breast abscess?
What is the treatment for Addison's disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.